![Frank Slack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Slack
Fondateur chez
Impilo Therapeutics, Inc.
Profil
Frank J.
Slack is the founder of Redona Therapeutics, Inc. founded in 2016.
Dr. Slack is also the founder of Impilo Therapeutics, Inc.,MiraDx, Inc. Dr. Slack is currently a Professor at Yale University.
Postes actifs de Frank Slack
| Sociétés | Poste | Début |
|---|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 05/07/2010 |
Impilo Therapeutics, Inc.
 Impilo Therapeutics, Inc. Packaged SoftwareTechnology Services Develops a platform for delivering nucleic acid-based medicines to solid tumor cancers | Fondateur | - |
Anciens postes connus de Frank Slack
| Sociétés | Poste | Fin |
|---|---|---|
Redona Therapeutics, Inc.
 Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Fondateur | - |
MiraDx, Inc.
 MiraDx, Inc. Medical/Nursing ServicesHealth Services Provides research and testing for cancer treatments | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiraDx, Inc.
MiraDx, Inc. Medical/Nursing ServicesHealth Services Provides research and testing for cancer treatments | Health Services |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Health Technology |
Impilo Therapeutics, Inc.
Impilo Therapeutics, Inc. Packaged SoftwareTechnology Services Develops a platform for delivering nucleic acid-based medicines to solid tumor cancers | Technology Services |
